Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review

BACKGROUND: Structured comparison of pharmacoeconomic analyses for ACEIs and ARBs in patients with type 2 diabetic nephropathy is still lacking. This review aims to systematically review the cost-effectiveness of both ACEIs and ARBs in type 2 diabetic patients with nephropathy. METHODS: A systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yunyu, Zhou, Qiyun, Haaijer-Ruskamp, Flora M, Postma, Maarten J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913790/
https://www.ncbi.nlm.nih.gov/pubmed/24428868
http://dx.doi.org/10.1186/1471-2369-15-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913790/
https://www.ncbi.nlm.nih.gov/pubmed/24428868
http://dx.doi.org/10.1186/1471-2369-15-15

Ejemplares similares